STRADB Antikörper (C-Term)

Produktnummer ABIN391172

Produktdetails anti-STRADB Antikörper

Target: STRADB (STE20-Related Kinase Adaptor beta (STRADB))

Bindungsspezifität: AA 274-303, C-Term

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser STRADB Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Aufreinigung: This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.

Immunogen: This ALS2CR2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 274-303 amino acids from the C-terminal region of human ALS2CR2.

Klon: RB15723

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: WB: 1:1000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.

Haltbarkeit: 6 months

Details zu STRADB

Target: STRADB (STE20-Related Kinase Adaptor beta (STRADB))

Andere Bezeichnung: ALS2CR2 (STRADB Produkte)

Synonyme: Als2cr2 antikoerper, RGD1559449 antikoerper, als2cr2 antikoerper, MGC82468 antikoerper, STRADB antikoerper, ALS2CR2 antikoerper, AA792893 antikoerper, B830008M19 antikoerper, D1Ucla2 antikoerper, ILPIP antikoerper, ILPIPA antikoerper, PRO1038 antikoerper, Papk antikoerper, Syradb antikoerper, CALS-21 antikoerper, PAPK antikoerper, STE20-related kinase adaptor beta antikoerper, STE20-related kinase adaptor beta L homeolog antikoerper, Stradb antikoerper, STRADB antikoerper, stradb.L antikoerper

Hintergrund: ALS2CR2 potentiates the antiapoptotic activity of XIAP by enhancing XIAP-mediated activation of JNK1 (MAPK8) and other JNK family members, but not by modulating XIAP-mediated caspase inhibition. Expression of a catalytically inactive TAK1 (MAP3K7) mutant blocks the XIAP/ALS2CR2 activation of JNK1. In vivo coprecipitation experiments show that both ALS2CR2 and XIAP interact with TAK1 and TRAF6. It has been proposed that XIAP-mediated protection from apoptosis utilizes both a JNK1 activation pathway that involves ALS2CR2 and a caspase inhibition pathway that is independent of ALS2CR2.

Molekulargewicht: 47026

Gen-ID: 55437

NCBI Accession: NP_001193793, NP_061041

UniProt: Q9C0K7

Pathways: AMPK Signaling